Δημοσιεύσεις

Κατάλογος ενδεικτικών δημοσιεύσεων του τμήματος Ιατρικής ΑΠΘ σε διεθνή επιστημονικά περιοδικά κατά τα τελευταία 5 έτη.

Export 22 results:
Συντάκτης Τίτλος Τύπος [ Έτος(Asc)]
Φίλτρα: Keyword is Taxoids  [Clear All Filters]
2016
Kotoula, V., Karavasilis V., Zagouri F., Kouvatseas G., Giannoulatou E., Gogas H., et al. (2016).  Effects of TP53 and PIK3CA mutations in early breast cancer: a matter of co-mutation and tumor-infiltrating lymphocytes.. Breast Cancer Res Treat. 158(2), 307-21.
Meille, C., Barbolosi D., Ciccolini J., Freyer G., & Iliadis A. (2016).  Revisiting Dosing Regimen Using Pharmacokinetic/Pharmacodynamic Mathematical Modeling: Densification and Intensification of Combination Cancer Therapy.. Clin Pharmacokinet. 55(8), 1015-25.
Hénin, E., Meille C., Barbolosi D., You B., Guitton J., Iliadis A., et al. (2016).  Revisiting dosing regimen using PK/PD modeling: the MODEL1 phase I/II trial of docetaxel plus epirubicin in metastatic breast cancer patients.. Breast Cancer Res Treat. 156(2), 331-41.
2015
Saridaki, Z., Lambrodimou G., Kachris S., Makrantonakis P., Boukovinas I., Polyzos A., et al. (2015).  Postoperative treatment with docetaxel, cisplatin, and capecitabine (DCX) and chemoradiotherapy (CRT) with capecitabine for resected gastric adenocarcinoma.. Am J Clin Oncol. 38(1), 17-22.
2014
Lakis, S., Kotoula V., Eleftheraki A. G., Batistatou A., Bobos M., Koletsa T., et al. (2014).  The androgen receptor as a surrogate marker for molecular apocrine breast cancer subtyping.. Breast. 23(3), 234-43.
Pentheroudakis, G., Kotoula V., Kouvatseas G., Charalambous E., Dionysopoulos D., Zagouri F., et al. (2014).  Association of VEGF-A splice variant mRNA expression with outcome in bevacizumab-treated patients with metastatic breast cancer.. Clin Breast Cancer. 14(5), 330-8.
Karavasilis, V., Kosmidis P., Syrigos K. N., Mavropoulou P., Dimopoulos M. A., Kotoula V., et al. (2014).  Docetaxel and intermittent erlotinib in patients with metastatic Non-Small Cell Lung Cancer; a phase II study from the Hellenic Cooperative Oncology Group.. Anticancer Res. 34(10), 5649-55.
Saloustros, E., Malamos N., Boukovinas I., Kakolyris S., Kouroussis C., Athanasiadis A., et al. (2014).  Dose-dense paclitaxel versus docetaxel following FEC as adjuvant chemotherapy in axillary node-positive early breast cancer: a multicenter randomized study of the Hellenic Oncology Research Group (HORG).. Breast Cancer Res Treat. 148(3), 591-7.
Chalvatzis, N., Manthou M. Eleni, Tzamalis A., Hytiroglou P., & Dimitrakos S. (2014).  Erosive conjunctival and corneal inflammatory changes in a patient receiving weekly docetaxel for breast cancer.. Ocul Immunol Inflamm. 22(2), 164-6.
Koutras, A. K., Kotoula V., Papadimitriou C., Dionysopoulos D., Zagouri F., Kalofonos H. P., et al. (2014).  Vascular endothelial growth factor polymorphisms and clinical outcome in patients with metastatic breast cancer treated with weekly docetaxel.. Pharmacogenomics J. 14(3), 248-55.
2013
Darwiche, K., Zarogoulidis P., Karamanos N. K., Domvri K., Chatzaki E., Constantinidis T. C., et al. (2013).  Efficacy versus safety concerns for aerosol chemotherapy in non-small-cell lung cancer: a future dilemma for micro-oncology.. Future Oncol. 9(4), 505-25.
Zarogoulidis, P., Petridis D., Ritzoulis C., Darwiche K., Spyratos D., Huang H., et al. (2013).  Establishing the optimal nebulization system for paclitaxel, docetaxel, cisplatin, carboplatin and gemcitabine: back to drawing the residual cup.. Int J Pharm. 453(2), 480-7.
2012
Pectasides, D., Papaxoinis G., Kotoula V., Fountzilas H., Korantzis I., Koutras A., et al. (2012).  Expression of angiogenic markers in the peripheral blood of docetaxel-treated advanced breast cancer patients: a Hellenic Cooperative Oncology Group (HeCOG) study.. Oncol Rep. 27(1), 216-24.
Korantzis, I., Kalogeras K. T., Papaxoinis G., Kotoula V., Koutras A., Soupos N., et al. (2012).  Expression of angiogenic markers in the peripheral blood of patients with advanced breast cancer treated with weekly docetaxel.. Anticancer Res. 32(10), 4569-80.
Kotoula, V., Krikelis D., Karavasilis V., Koletsa T., Eleftheraki A. G., Televantou D., et al. (2012).  Expression of DNA repair and replication genes in non-small cell lung cancer (NSCLC): a role for thymidylate synthetase (TYMS).. BMC Cancer. 12, 342.
2010
Chelis, L., Xenidis N., Amarantidis K., Prassopoulos P., Chamalidou E., Neanidis K., et al. (2010).  Biweekly vinorelbine and gemcitabine as second-line treatment and beyond in non-small cell lung cancer.. Chemotherapy. 56(5), 353-8.
Molife, L. R., Fong P. C., Paccagnella L., Reid A. H. M., Shaw H. M., Vidal L., et al. (2010).  The insulin-like growth factor-I receptor inhibitor figitumumab (CP-751,871) in combination with docetaxel in patients with advanced solid tumours: results of a phase Ib dose-escalation, open-label study.. Br J Cancer. 103(3), 332-9.
Bamias, A., Karina M., Papakostas P., Kostopoulos I., Bobos M., Vourli G., et al. (2010).  A randomized phase III study of adjuvant platinum/docetaxel chemotherapy with or without radiation therapy in patients with gastric cancer.. Cancer Chemother Pharmacol. 65(6), 1009-21.
2009
Maniadakis, N., Dafni U., Fragoulakis V., Grimani I., Galani E., Fragkoulidi A., et al. (2009).  Economic evaluation of taxane-based first-line chemotherapy in the treatment of patients with metastatic breast cancer in Greece: an analysis alongside a multicenter, randomized phase III clinical trial.. Ann Oncol. 20(2), 278-85.
Fountzilas, G., Bamias A., Kalogera-Fountzila A., Karayannopoulou G., Bobos M., Athanassiou E., et al. (2009).  Induction chemotherapy with docetaxel and cisplatin followed by concomitant chemoradiotherapy in patients with inoperable non-nasopharyngeal carcinoma of the head and neck.. Anticancer Res. 29(2), 529-38.
Fountzilas, G., Dafni U., Dimopoulos M. A., Koutras A., Skarlos D., Papakostas P., et al. (2009).  A randomized phase III study comparing three anthracycline-free taxane-based regimens, as first line chemotherapy, in metastatic breast cancer: a Hellenic Cooperative Oncology Group study.. Breast Cancer Res Treat. 115(1), 87-99.
Papadimitriou, C. A., Kalofonos H., Zagouri F., Papakostas P., Bozas G., Makatsoris T., et al. (2009).  Weekly docetaxel with or without gemcitabine as second-line chemotherapy in paclitaxel-pretreated patients with metastatic breast cancer: a randomized phase II study conducted by the Hellenic Co-Operative Oncology Group.. Oncology. 77(3-4), 212-6.

Επικοινωνία

Τμήμα Ιατρικής, Πανεπιστημιούπολη ΑΠΘ, T.K. 54124, Θεσσαλονίκη
 

Συνδεθείτε

Το τμήμα Ιατρικής στα κοινωνικά δίκτυα.
Ακολουθήστε μας ή συνδεθείτε μαζί μας.

           

Σύνδεσμοι

 

Το πανεπιστήμιο

 
 

Προσωπικό & Φοιτητές